(Q36577097)

15 August 2017

1 reference

title

Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin (English)

1 reference

15 August 2017

1 reference

1 reference

Christoph Thiemermann

series ordinal

2

object named as

Christoph Thiemermann

1 reference

15 August 2017

Edward J Sharples

1

1 reference

15 August 2017

Magdi M Yaqoob

series ordinal

3

1 reference

15 August 2017

publication date

1 December 2005

1 reference

Nature Clinical Practice Nephrology

15 August 2017

published in

1 reference

15 August 2017

volume

1

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

87-97

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

15 August 2017

1 reference

Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

Intravital videomicroscopy of peritubular capillaries in renal ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

Hospital-acquired renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Spectrum of acute renal failure in the intensive care unit: the PICARD experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

ARF after open-heart surgery: Influence of gender and race

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Difficulties in understanding human "acute tubular necrosis": limited data and flawed animal models

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Identification of the renal erythropoietin-producing cells using transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

HIF-1: an oxygen response system with special relevance to the kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

In vivo evidence that erythropoietin protects neurons from ischemic damage

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin in the brain: can the promise to protect be fulfilled?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Human, rat, and mouse kidney cells express functional erythropoietin receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Microvascular endothelial injury and dysfunction during ischemic acute renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Endothelial injury and dysfunction: role in the extension phase of acute renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Hypoxia of the renal medulla--its implications for disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Regional responses within the kidney to ischemia: assessment of adenine nucleotide and catabolite profiles

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

The predictive value of 5′-adenine nucleotide depletion and replenishment in ischaemic rabbit kidney tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Apoptosis in ischemic renal injury: roles of GTP depletion and p53.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Reactive oxygen species and acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Activation of mitochondrial apoptotic pathways in human renal allografts after ischemiareperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Apoptosis and inflammation in renal reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Cloning and expression of rat caspase-6 and its localization in renal ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Apoptosis and chemokine induction after renal ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin protects against ischaemic acute renal injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Study of the actions of human recombinant erythropoietin on rat renal haemodynamics

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin administration in vivo increases vascular nitric oxide synthase expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid Communication

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Whispers and shouts in the pathogenesis of acute renal ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Inflammatory cells in ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Is the proximal tubular cell a proinflammatory cell?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Derivatives of erythropoietin that are tissue protective but not erythropoietic

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0042

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0042

1 reference

15 August 2017

1 reference